Cosmos Health Shares Are Trading Higher After the Company Announced That, Pursuant to Its Agreement With Virax Biolabs, It Continues to Hold the Rights to Distribute Mpox Virus Real-time PCR Detection Kits, With Exclusive Distribution Rights in Greece...
Cosmos Health Shares Are Trading Higher After the Company Announced That, Pursuant to Its Agreement With Virax Biolabs, It Continues to Hold the Rights to Distribute Mpox Virus Real-time PCR Detection Kits, With Exclusive Distribution Rights in Greece...
阿童木健康股份正在交易上漲，該公司宣佈根據其與Virax Biolabs的協議，繼續持有Mpox病毒實時PCR檢測套件的分銷權，在希臘享有獨家分銷權...
Cosmos Health Shares Are Trading Higher After the Company Announced That, Pursuant to Its Agreement With Virax Biolabs, It Continues to Hold the Rights to Distribute Mpox Virus Real-time PCR Detection Kits, With Exclusive Distribution Rights in Greece and Cyprus, and Non-exclusive Distribution Rights Across Europe.
阿童木健康公司的股票交易較高，因爲該公司宣佈根據其與Virax Biolabs的協議，繼續持有分發Mpox病毒實時PCR檢測試劑盒的權利，在希臘和塞浦路斯擁有獨家分銷權，在歐洲其他地區擁有非獨家分銷權。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。